Pieris Pharmaceuticals, Inc. (PIRS) earnings
Quarterly and annual PIRS reports and results, each read against the price at its own news timestamp. Back to the PIRS overview →
6 measured PIRS earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PIERIS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | — | -0.37% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.81% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.17% | |
| Form 10-K/A PIERIS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.60% | |
| Form 10-K PIERIS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -0.05% | -1.58% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +0.17% | +0.61% |
Keep exploring
More PIRS: analyst actions → · SEC filings → · PIRS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ORGANIGRAM HOLDINGS INC (OGRMF) | 97 | +0.25% | 56% |
| Utah Medical Products, Inc. (UTMD) | 96 | 0.00% | 48% |
| ASTELLAS PHARMA UNSP/ADR (ALPMY) | 94 | +0.02% | 50% |
| Check-Cap Ltd. - Ordinary Share (CHEK) | 94 | -0.11% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.